These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32821044)

  • 21. Phase I trials as valid therapeutic options for patients with cancer.
    Adashek JJ; LoRusso PM; Hong DS; Kurzrock R
    Nat Rev Clin Oncol; 2019 Dec; 16(12):773-778. PubMed ID: 31477881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation.
    Hu T; Wang L; Pan X; Qi H
    Expert Opin Ther Pat; 2016 Aug; 26(8):857-60. PubMed ID: 27097290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyspecific organic cation transporters and their biomedical relevance in kidney.
    Koepsell H
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):533-8. PubMed ID: 23852330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth.
    Schmidt P; Abken H
    Oncotarget; 2011 Apr; 2(4):313-20. PubMed ID: 21487158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging strategies for the treatment of tumor stem cells in central nervous system malignancies.
    Khan IS; Ehtesham M
    Adv Exp Med Biol; 2015; 853():167-87. PubMed ID: 25895712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological aspects of chondrosarcoma: Leaps and hurdles.
    Mery B; Espenel S; Guy JB; Rancoule C; Vallard A; Aloy MT; Rodriguez-Lafrasse C; Magné N
    Crit Rev Oncol Hematol; 2018 Jun; 126():32-36. PubMed ID: 29759564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role in oncology and targeting of the PTK7 tyrosine kinase receptor].
    Ganier L; Morelli X; Borg JP
    Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():42-46. PubMed ID: 33052093
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeting cell division cycle 7 kinase: a new approach for cancer therapy.
    Montagnoli A; Moll J; Colotta F
    Clin Cancer Res; 2010 Sep; 16(18):4503-8. PubMed ID: 20647475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapeutics in refractory renal cell carcinoma.
    Koshkin VS; Rini BI
    Expert Opin Pharmacother; 2016 Jun; 17(9):1225-32. PubMed ID: 27112171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes-Tasimelteon as an Example.
    Preskorn SH
    J Psychiatr Pract; 2017 Nov; 23(6):425-430. PubMed ID: 29303950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise.
    Kashkar H
    Clin Cancer Res; 2010 Sep; 16(18):4496-502. PubMed ID: 20682709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.
    Morozova O; Vojvodic M; Grinshtein N; Hansford LM; Blakely KM; Maslova A; Hirst M; Cezard T; Morin RD; Moore R; Smith KM; Miller F; Taylor P; Thiessen N; Varhol R; Zhao Y; Jones S; Moffat J; Kislinger T; Moran MF; Kaplan DR; Marra MA
    Clin Cancer Res; 2010 Sep; 16(18):4572-82. PubMed ID: 20651058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic lymphocytic leukemia].
    Jacque N; Leblond V
    Presse Med; 2019; 48(7-8 Pt 1):807-815. PubMed ID: 31447332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel investigational biologics for the treatment of cancer cachexia.
    Ma JD; Heavey SF; Revta C; Roeland EJ
    Expert Opin Biol Ther; 2014 Aug; 14(8):1113-20. PubMed ID: 24707881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of organic anion transporters and organic cation transporters with mycotoxins.
    Tachampa K; Takeda M; Khamdang S; Noshiro-Kofuji R; Tsuda M; Jariyawat S; Fukutomi T; Sophasan S; Anzai N; Endou H
    J Pharmacol Sci; 2008 Mar; 106(3):435-43. PubMed ID: 18319568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting microRNAs in heart failure.
    Duygu B; de Windt LJ; da Costa Martins PA
    Trends Cardiovasc Med; 2016 Feb; 26(2):99-110. PubMed ID: 26119078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision medicine for managing diabetes.
    Klonoff DC
    J Diabetes Sci Technol; 2015 Jan; 9(1):3-7. PubMed ID: 25550409
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cystic fibrosis: new treatments targeting the CFTR protein].
    Fajac I; Sermet-Gaudelus I
    Rev Mal Respir; 2013 Apr; 30(4):255-61. PubMed ID: 23664284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Brain Research Organization--Seventh World Congress of Neuroscience. 12-17 July 2007, Melbourne, Victoria, Australia.
    Hannan AJ
    IDrugs; 2007 Oct; 10(10):690-2. PubMed ID: 17899483
    [No Abstract]   [Full Text] [Related]  

  • 40. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
    Bacq A; Balasse L; Biala G; Guiard B; Gardier AM; Schinkel A; Louis F; Vialou V; Martres MP; Chevarin C; Hamon M; Giros B; Gautron S
    Mol Psychiatry; 2012 Sep; 17(9):926-39. PubMed ID: 21769100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.